Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Verrelle

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
HLA|October 17, 2023
Temporal regulation of transgene expression controlled by amino acid availability in human T cellsAurore Dougé, Cyrielle Vituret, Valérie Carraro, et al.
Cancers|August 27, 2021
CENP-A Subnuclear Localization Pattern as Marker Predicting Curability by Chemoradiation Therapy for Locally Advanced Head and Neck Cancer PatientsPierre Verrelle, Didier Meseure, Frédérique Berger, et al.
Acta Neuropathologica Communications|November 11, 2019
The level of activity of the alternative lengthening of telomeres correlates with patient age in IDH-mutant ATRX-loss-of-expression anaplastic astrocytomasNathalie Grandin, Bruno Pereira, Camille Cohen, et al.
Carcinogenesis|January 1, 2016
The tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients' survivalAnne Fogli, Emmanuel Chautard, Catherine Vaurs-Barrière, et al.
Oral Oncology|July 10, 2017
Very accelerated radiotherapy or concurrent chemoradiotherapy for N3 head and neck squamous cell carcinoma: Pooled analysis of two GORTEC randomized trialsYungan Tao, Anne Aupérin, Pierre Graff, et al.
Brain Pathology (Zurich, Switzerland)|March 5, 2015
STAT3 Serine 727 Phosphorylation: A Relevant Target to Radiosensitize Human GlioblastomaZangbéwendé Guy Ouédraogo, Mélanie Müller-Barthélémy, Jean-Louis Kemeny, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 8, 2025
Sparing effects of FLASH irradiation in patient-derived lung tissueMaxime Dubail, Chloé Lafouasse, Sophie Heinrich, et al.
European Journal of Cancer (Oxford, England : 1990)|April 10, 2013
αvβ3 Integrin and Fibroblast growth factor receptor 1 (FGFR1): Prognostic factors in a phase I-II clinical trial associating continuous administration of Tipifarnib with radiotherapy for patients with newly diagnosed glioblastomaAnne Ducassou, Emmanuelle Uro-Coste, Pierre Verrelle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2019
FLASH Irradiation Spares Lung Progenitor Cells and Limits the Incidence of Radio-induced SenescenceCharles Fouillade, Sandra Curras-Alonso, Lorena Giuranno, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 2023
Integrated High-Throughput Screening and Large-Scale Isobolographic Analysis to Accelerate the Discovery of Radiosensitizers With Greater Selectivity for Cancer CellsPierre Verrelle, Pierre Gestraud, Florent Poyer, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
HLA|October 17, 2023
Temporal regulation of transgene expression controlled by amino acid availability in human T cellsAurore Dougé, Cyrielle Vituret, Valérie Carraro, et al.
Cancers|August 27, 2021
CENP-A Subnuclear Localization Pattern as Marker Predicting Curability by Chemoradiation Therapy for Locally Advanced Head and Neck Cancer PatientsPierre Verrelle, Didier Meseure, Frédérique Berger, et al.
Acta Neuropathologica Communications|November 11, 2019
The level of activity of the alternative lengthening of telomeres correlates with patient age in IDH-mutant ATRX-loss-of-expression anaplastic astrocytomasNathalie Grandin, Bruno Pereira, Camille Cohen, et al.
Carcinogenesis|January 1, 2016
The tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients' survivalAnne Fogli, Emmanuel Chautard, Catherine Vaurs-Barrière, et al.
Oral Oncology|July 10, 2017
Very accelerated radiotherapy or concurrent chemoradiotherapy for N3 head and neck squamous cell carcinoma: Pooled analysis of two GORTEC randomized trialsYungan Tao, Anne Aupérin, Pierre Graff, et al.
Brain Pathology (Zurich, Switzerland)|March 5, 2015
STAT3 Serine 727 Phosphorylation: A Relevant Target to Radiosensitize Human GlioblastomaZangbéwendé Guy Ouédraogo, Mélanie Müller-Barthélémy, Jean-Louis Kemeny, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 8, 2025
Sparing effects of FLASH irradiation in patient-derived lung tissueMaxime Dubail, Chloé Lafouasse, Sophie Heinrich, et al.
European Journal of Cancer (Oxford, England : 1990)|April 10, 2013
αvβ3 Integrin and Fibroblast growth factor receptor 1 (FGFR1): Prognostic factors in a phase I-II clinical trial associating continuous administration of Tipifarnib with radiotherapy for patients with newly diagnosed glioblastomaAnne Ducassou, Emmanuelle Uro-Coste, Pierre Verrelle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2019
FLASH Irradiation Spares Lung Progenitor Cells and Limits the Incidence of Radio-induced SenescenceCharles Fouillade, Sandra Curras-Alonso, Lorena Giuranno, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 2023
Integrated High-Throughput Screening and Large-Scale Isobolographic Analysis to Accelerate the Discovery of Radiosensitizers With Greater Selectivity for Cancer CellsPierre Verrelle, Pierre Gestraud, Florent Poyer, et al.
Pageof 9